Please note that all emails sent by OKCHEM are from ***@okchem.com, service@mail. okchemvip.com, or notifications@edm-okchem.com. Please be alert of other emails sent to you in the name of OKCHEM.

United States Biopharmaceuticals 2017

By: CPhI 2019.05.27

Report Description

A global powerhouse and forerunner on the international stage, the U.S. biopharmaceutical industry is framed by uncertainty in light of the country’s recent political transition. Nevertheless, the industry is robust and ready to adapt, already reacting to recent negative media attention relating to drug pricing and price increases. With an increasing amount of innovation stemming from small biotechnology companies and projects spun out from universities into start-ups, the importance of fostering innovation and providing a supportive framework is paramount. Regional hubs with flourishing innovation ecosystems are notable for the incentives they offer and, as such, have become centers for innovation and knowledge exchange.

Table of Contents

Introducing the U.S. Biopharmaceutical Industry


Navigating the Regulatory Framework


The East Coast and Surrounding Ecosystem


The Industry’s Backbone: Research and Development


Manufacturing: Demand Spurring Diversifcation


The Indispensible Partner: Contract Services


Supply Chain, Distribution and Logistics

 
The Biopharmaceutical Industry Outlook


Tables and Figures


Share it: United States Biopharmaceuticals 2017 United States Biopharmaceuticals 2017 United States Biopharmaceuticals 2017 United States Biopharmaceuticals 2017

c